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Introduction {#sec1}
============

Pluripotent stem cells (PSCs) can self-renew unlimitedly and have the potential to differentiate into all somatic and germ cell types. PSCs can be derived from the inner cell mass (ICM) of blastocyst or implanted epiblast cells ([@bib21], [@bib29]). ICM and epiblast cells are pluripotent cells but not bona fide stem cells in vivo, as they differentiate to eventually establish the three germ layers in the gastrulating embryo. Both cell populations can be grown as PSCs when they are cultured in vitro with stem cell maintenance medium. Interestingly, the ICM of blastocysts forms "naive" pluripotent embryonic stem cells (ESCs) and epiblast cells form "primed" pluripotent epiblast stem cells (EpiSCs) ([@bib21]). Primed PSCs have limited differentiation potential in vivo; they barely contribute to chimeras by blastocyst injection analysis. Primed PSCs maintain stemness through basic fibroblast growth factor (bFGF) and Activin/Nodal signaling pathways ([@bib5], [@bib18], [@bib47]) but not by STAT3 and bone morphogenetic protein 4 pathways ([@bib29]). These two PSCs exhibit different molecular signatures but still share many important markers. One of the commonly expressed genes in these cells is *Oct4*, which is a PSC and germ cell marker ([@bib39]). In addition to maintenance of PSCs, *Oct4* alone can transform differentiated cells into PSCs, referred to as induced PSCs (iPSCs) ([@bib24]). The *Oct4* gene contains three distinct *cis*-regulatory elements: the proximal promoter (PP), the distal enhancer (DE), and the proximal enhancer (PE), which differentially control *Oct4* expression during embryogenesis ([@bib52]). Although *Oct4* is expressed in both naive and primed PSCs, the regulatory mechanism of *Oct4* expression differs between these cell types; *Oct4* expression in naive and primed pluripotent cells is differentially controlled by DE and PE, respectively ([@bib5], [@bib43], [@bib52]). Accordingly, enhancer activity is altered as primed PSCs are converted into naive PSCs through the induction of extrinsic signaling or genetic modification ([@bib1], [@bib19], [@bib20]).

Two recent reports used the *Oct4*-ΔPE-GFP marker to discriminate naive human PSCs from primed human PSCs ([@bib15], [@bib44]). However, as shown in flow cytometry data in [@bib44], *Oct4*-ΔPE-GFP reporter activity is not completely negative (including weak GFP activity) in primed human ESCs. Moreover, the *Oct4*-ΔPE-GFP^+^ cells may still include ESCs utilizing *Oct4*-PE, since a mono-transgenic system cannot discriminate between cells using only *Oct4*-DE and cells using both *Oct4*-PE and *Oct4*-DE, which may constitute an impure population of naive PSCs. Therefore, in this study we established a dual reporter system for naive and primed mouse pluripotent cells, using two fluorescent reporters, GFP and tdTomato (RFP), controlled by the *cis*-regulatory elements DE and PE, respectively. We found that the expression of *Oct4*-ΔPE-GFP and *Oct4*-ΔDE-RFP accurately represents the expression of naive and primed cells during the development of double transgenic mice. Thus, this double transgenic system can reproduce the in vivo *Oct4* regulatory system, providing a tool for studying the regulation of naive and primed pluripotency and enabling the separation of pure populations of naive and primed PSCs.

Results {#sec2}
=======

Generation of Dual-Color Fluorescence Transgenic Mice Containing *Oct4*-ΔPE-GFP and *Oct4*-ΔDE-RFP {#sec2.1}
--------------------------------------------------------------------------------------------------

*Oct4* is expressed in both naive and primed PSCs. However, *Oct4* expression in naive and primed pluripotent cells is differentially controlled by two regulatory elements, DE and PE, respectively. We intended to understand how *Oct4* is regulated by DE and PE during development ([Figure 1](#fig1){ref-type="fig"}). Therefore, we generated double transgenic mice expressing GFP and RFP under the control of either DE or PE of *Oct4*, respectively. O4-DE-GFP mice carried the *Oct4*-ΔPE-GFP transgene, originally termed OG2 ([@bib41]), and O4-PE-RFP mice carried the *Oct4*-ΔDE-RFP transgene ([Figure 1](#fig1){ref-type="fig"}A). Five O4-PE-RFP founder transgenic mice (two male and three female) were generated ([Figure S1](#mmc1){ref-type="supplementary-material"}). O4-PE-RFP mice were crossed with homozygous O4-DE-GFP mice, and subsequently O4-DE-GFP^+/−^/O4-PE-RFP^+/+^ double transgenic mice were derived ([Figure 1](#fig1){ref-type="fig"}A). O4-DE-GFP^+/−^/O4-PE-RFP^+/−^ embryos were obtained from wild-type female mice after crossing them with O4-DE-GFP^+/−^/O4-PE-RFP^+/+^ male mice. All transgenic animals that were studied for their expression had one allele of each transgene (O4-DE-GFP^+/−^/O4-PE-RFP^+/−^). In all transgenic animals both endogenous *Oct4* alleles were present.

O4-DE-GFP and O4-PE-RFP Recapitulate the Stage-Specific Expression of *Oct4* during Mouse Embryo Development {#sec2.2}
------------------------------------------------------------------------------------------------------------

Two-cell-stage embryos did not express either GFP nor RFP ([Figure 1](#fig1){ref-type="fig"}B), in agreement with the zygotic genome not being active at this stage. GFP was initially detected in eight-cell embryos and was strongly expressed at the ICM of the blastocyst stage, whereas RFP was not detected even at the blastocyst stage ([Figure 1](#fig1){ref-type="fig"}B), indicating that PE is dispensable for *Oct4* expression in the pre-implantation embryo.

Next, we observed the expression of O4-DE-GFP and O4-PE-RFP during the post-implantation stages (6.5--13.5 days post coitum \[dpc\]). The 5.5- and 6.5-dpc epiblasts were positive both for GFP and RFP ([Figures 1](#fig1){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}). At 7.25 dpc the intensity of the GFP signal decreased, but the RFP signal remained strong in epiblast cells ([Figure 1](#fig1){ref-type="fig"}D). Primordial germ cells (PGCs) were not distinguishable at this stage. However, at 8.5 dpc, GFP-positive cells were localized to the posterior regions of the embryos where the PGCs form a cluster and begin migrating into the genital ridge ([Figure 1](#fig1){ref-type="fig"}E). Although RFP-positive cells were detected extensively at the posterior regions of the embryos, these cells did not overlap with the GFP-positive cells, indicating that early PGCs do not require PE for *Oct4* expression. At 9.5 dpc, GFP-positive cells were detected in the hindgut area ([Figure 1](#fig1){ref-type="fig"}F). RFP-positive cells disappeared from the soma; however, some cells in the hindgut expressed both RFP and GFP (approximately 34.7%), indicating that migratory PGCs at 9.5 dpc can be divided into two populations: GFP^+^ and GFP^+^/RFP^+^ cells. At the 10.5-dpc stage, when getting close to the genital ridge, most PGCs expressed both *Oct4*-GFP and -RFP ([Figure 1](#fig1){ref-type="fig"}G). This was also the case once the PGCs arrived at and proliferated in the gonads (13.5 dpc; [Figure 1](#fig1){ref-type="fig"}H). These results demonstrate that the two regulatory regions, DE and PE, dynamically control *Oct4* expression during embryonic development and that founder PGCs use DE while migratory as well as post-migratory PGCs employ both DE and PE to drive *Oct4* expression.

*Oct4* has been shown to be expressed in mitotically arrested prospermatogonia and type A spermatogonia, but is downregulated in type B spermatogonia and spermatocytes in adult testis ([@bib35]). Expression of both GFP and RFP was detected 7 days postpartum (dpp) in the seminiferous tubules of male transgenic testis ([Figure 1](#fig1){ref-type="fig"}I). Interestingly, although both GFP^+^ and RFP^+^ cells were detected in 4-week-old adult male mouse testis, only GFP^+^ cells were localized to the periphery (near the basement membrane) of the seminiferous tubules while RFP^+^ cells were detected at the center of the seminiferous tubules ([Figure 1](#fig1){ref-type="fig"}J). Immunohistochemistry analysis confirmed that the GFP^+^ cells are present at the periphery (type A spermatogonia niche) of the seminiferous tubules and that the RFP^+^ cells are detected at the center (differentiated germ cell niche) of the seminiferous tubules ([Figure S3](#mmc1){ref-type="supplementary-material"}). These results indicate that type A spermatogonia at the pre-meiotic division stage (7 dpp) can use both DE and PE to express *Oct4* but that in adult testis only DE drives *Oct4* expression in type A spermatogonia of 4-week-old mice. Committed germ cells located near the lumen also express *Oct4*, which is controlled by PE.

In this study, we focused on spermatogenic cells since RFP was not detected in the transgenic ovary. We did not detect transgenic expression in somatic cells. For example, we detected neither a GFP nor an RFP signal in neural stem cells (NSCs) ([Figure 1](#fig1){ref-type="fig"}K), demonstrating that our transgenic system is specific for the germline, i.e., PSCs and germ cells, but not for somatic stem cells. Taken together, our results indicate that DE and PE activities stage-specifically regulate expression of *Oct4* in totipotent/pluripotent cells and germ cells in the developing mouse embryo.

Derivation of ESCs from Dual-Color Fluorescence Transgenic Blastocysts {#sec2.3}
----------------------------------------------------------------------

Previous studies have suggested that ESCs grown under conventional ESC culture conditions are a heterogeneous population ([@bib22], [@bib27], [@bib28]). Thus, we attempted to verify the heterogeneity of ESCs and derive a pure population of naive pluripotent ESCs, using our double transgenic system. Blastocysts were plated on a feeder-layered dish in conventional mouse ESC medium (serum + leukemia inhibitory factor \[LIF\]) ([Figures 2](#fig2){ref-type="fig"}A and 2B). Initially the ICM of blastocysts expressed only GFP, whereas RFP was expressed after 3 days. As the ICM outgrowths expanded, the GFP^+^RFP^−^ cells became GFP^+^RFP^+^ cells ([Figure 2](#fig2){ref-type="fig"}B). This result supports a previous study demonstrating that pluripotent ESC derivation requires epiblast specification ([@bib4]). This in vitro culture system indirectly suggests that during the 4.5- to 5.5-dpc embryonic development, GFP^+^RFP^−^ cells may be gradually changed into GFP^+^RFP^+^ cells in vivo. Trypsinized ICM outgrowth cells were transferred into a new dish with serum + LIF medium where two distinct ESC populations were cultured (GFP^+^RFP^−^ and GFP^+^RFP^+^; [Figure 2](#fig2){ref-type="fig"}C). Fluorescence-activated cell sorting analysis showed that during the initial stage of ESC derivation in serum + LIF the GFP^+^RFP^−^ cells, presumably naive PSCs, constituted only 72.7%, while GFP^+^RFP^+^ and GFP^−^RFP^+^ cells constituted 22.1% and 0.49%, respectively, of the population ([Figure 2](#fig2){ref-type="fig"}D). When GFP^+^RFP^−^ cells were sorted and recultured in serum + LIF medium, GFP^+^RFP^−^ cells reverted to GFP^+^RFP^+^ subsequent to ten passages ([Figure 2](#fig2){ref-type="fig"}E). In contrast, when GFP^+^RFP^+^ cells were sorted and cultured in serum + LIF medium, GFP^+^RFP^+^ cells reverted to GFP^+^RFP^−^ cells subsequent to ten passages ([Figure 2](#fig2){ref-type="fig"}E). These results demonstrate that the ESCs in serum + LIF medium were heterogeneous; they contained two populations of cell types that were interconvertible. These GFP^+^RFP^+^ and GFP^+^RFP^−^ cell populations could not have been distinguished using an *Oct4*-ΔPE-GFP mono-transgenic system.

Next, we modified the culture conditions by adding two inhibitors (2i), ERK1/2 (PD0325901) and GSK3 (CHIR99021), into the serum + LIF medium. Previous reports have demonstrated that these 2i contributed to the establishment of naive PSCs and shielded PSCs from differentiation triggers ([@bib54]). Under serum + LIF + 2i conditions, only 76.0% of cells were GFP^+^RFP^−^ and 23.0% were GFP^+^RFP^+^ ([Figures 2](#fig2){ref-type="fig"}F and 2G). When the GFP^+^RFP^−^ cells were sorted and cultured for ten passages under serum + LIF + 2i conditions, 3.45% became GFP^+^RFP^+^ ([Figure 2](#fig2){ref-type="fig"}H, left panel). In contrast, the sorted GFP^+^RFP^+^ cells also converted into GFP^+^RFP^−^ cells (70.1%) ([Figure 2](#fig2){ref-type="fig"}H, right panel). These findings indicate that serum + LIF + 2i culture conditions are insufficient for the maintenance of GFP^+^RFP^−^ cells. Thus, ESCs are metastable and interconvertible between GFP^+^RFP^−^ and GFP^+^RFP^+^ cells in serum-containing medium. Next, we used the new culture medium to obtain a pure population of naive PSCs. Serum was removed from the medium since mouse ESCs exhibited elevated levels of ERK1/2 phosphorylation, a key event in priming of ESCs for differentiation ([@bib25], [@bib49], [@bib51]), in serum-containing medium. Serum-free ESC culture medium (N2B27 medium) supplemented with 2i in combination with LIF ([@bib26], [@bib40], [@bib54]) was used for ESC culturing. ESCs (from serum + LIF culture) were transferred into N2B27 + LIF + 2i medium. On day 2 after transfer to the N2B27 + LIF + 2i medium ([Figure 2](#fig2){ref-type="fig"}I), most GFP^+^RFP^+^ cells were converted into GFP^+^RFP^−^ cells (98.9%; [Figure 2](#fig2){ref-type="fig"}J). Subsequent to further culturing, nearly all cells were maintained as GFP^+^RFP^−^ cells (94.3%; [Figure 2](#fig2){ref-type="fig"}K). Next, the ESCs (from N2B27 + LIF + 2i medium) were transferred into serum + LIF medium. Subsequent to 2 days of culturing, nearly all of the GFP^+^RFP^−^ cells were converted into GFP^+^RFP^+^ cells (67.2%; [Figure 2](#fig2){ref-type="fig"}L). Taken together, our double transgenic system unequivocally shows that the ESCs in serum-containing medium were heterogeneous. This heterogeneous ESC population became homogeneous subsequent to culturing in serum-free medium supplemented with 2i and LIF. Therefore, serum-free culture condition is an essential requirement for culturing a pure population of naive PSCs.

Distinct Gene Expression Patterns in 2i-GFP-, GFP-, and GFP/RFP-Positive ESCs {#sec2.4}
-----------------------------------------------------------------------------

*Oct4* expression is controlled by the DE in naive PSCs, while the PE regulates *Oct4* expression in primed PSCs ([@bib5], [@bib43], [@bib52]). Therefore, we investigated whether the expression of *Oct4*-ΔPE-GFP and *Oct4*-ΔDE-RFP accurately represents the naive and primed PSC states in an in vitro culture system. We compared the global gene expression patterns of GFP^+^RFP^−^ (from N2B27 + LIF + 2i and serum + LIF medium) and GFP^+^RFP^+^ cells (from serum + LIF) using microarray analysis (Illumina MouseRef-8 v2 Expression BeadChip). Surprisingly, the gene expression profile of GFP^+^RFP^−^ cells cultured in N2B27 + LIF + 2i (2i-GFP^+^RFP^−^) was distinct from that of GFP^+^RFP^−^ cells cultured in serum + LIF ([Figure 3](#fig3){ref-type="fig"}A). The hierarchical clustering and multidimensional scaling (MDS) plot analyses showed that the gene expression pattern of GFP^+^RFP^−^ cells was more similar to GFP^+^RFP^+^ cells than to 2i-GFP^+^RFP^−^ cells ([Figures 3](#fig3){ref-type="fig"}B and 3C). Pairwise scatter-plot analyses also demonstrated that GFP^+^RFP^+^ cells were almost identical to GFP^+^RFP^−^ cells (0.998), which were distinct from 2i-GFP^+^RFP^−^ cells ([Figures 3](#fig3){ref-type="fig"}D--3F). Differentially expressed genes in GFP^+^RFP^−^ and GFP^+^RFP^+^ cells were largely associated with germline development; GFP^+^RFP^−^ cells highly expressed *Wnt3a*, *Rhox5*, *Rhox6*, *Rhox9*, *Nanos3*, and *Tcfap2c* ([Figure 3](#fig3){ref-type="fig"}G). We found that 249 genes were upregulated and 446 genes were downregulated in 2i-GFP^+^RFP^−^ versus GFP^+^RFP^−^ cells ([Figure S4](#mmc1){ref-type="supplementary-material"}A). The expression levels of pluripotency factors such as *Pou5f1* (*Oct4*), *Nanog*, *Zfp42* (*Rex1*), *Esrrb*, *Sall4*, and *Lin28* were almost identical in 2i-GFP^+^RFP^−^, GFP^+^RFP^−^, and GFP^+^RFP^+^ cells ([Figure 3](#fig3){ref-type="fig"}H). However, the naive pluripotency markers, *Klf4*, *Tcl1*, and *Tbx3*, were more highly expressed in 2i-GFP^+^RFP^−^ than in GFP^+^RFP^−^ and GFP^+^RFP^+^ cells. In contrast, differentiation-related genes such as *Dnmt3b*, *Brachyury* (*T*), *Otx2*, and *Fgf5* were more highly upregulated in GFP^+^RFP^−^ and GFP^+^RFP^+^ cells than in 2i-GFP^+^RFP^−^ cells. These gene expression patterns were further confirmed by qRT-PCR analysis ([Figure 3](#fig3){ref-type="fig"}I). The expression levels of the pluripotency markers (*Oct4*, *Nanog*, *Sox2*, *Rex1*, *Esrrb*, and *Klf2*) in 2i-GFP^+^RFP^−^ cells were similar to those in GFP^+^RFP^−^ and GFP^+^RFP^+^ cells ([Figure 3](#fig3){ref-type="fig"}I). However, while naive pluripotency markers were upregulated in 2i-GFP^+^RFP^−^ cells, the development-related genes were downregulated ([Figure S4](#mmc1){ref-type="supplementary-material"}B). These findings suggest that although GFP^+^RFP^−^ cells display more naive characteristics (such as higher expression of germ cell markers) under serum + LIF culture conditions, they are in a metastable state and are readily converted into GFP^+^RFP^+^ cells. Stable naive PSCs could be maintained only in serum-free N2B27 + LIF + 2i medium, since 2i-GFP^+^RFP^−^ cells were found to be distinct from GFP^+^RFP^−^ cells cultured in serum-containing medium and expressed a greater number of naive pluripotency markers.

Functional annotation clustering of differentially expressed genes using gene ontology (GO) analysis revealed that the upregulated genes (\>2-fold) in 2i-GFP^+^RFP^−^ cells were significantly enriched for GO terms linked to "sterol biosynthetic and metabolic process," "cholesterol biosynthetic and metabolic process," and "lipid biosynthetic process" ([@bib26]) ([Table S1](#mmc1){ref-type="supplementary-material"}). The upregulated genes in GFP^+^RFP^−^ or GFP^+^RFP^+^ cells were enriched for GO terms linked to "gland, tube development, and developmental growth," "collagen metabolic and catabolic process," "membrane organization," and "germ cell development" ([Table S2](#mmc1){ref-type="supplementary-material"}).

GFP^−^RFP^+^ Cells Represent Primed PSCs {#sec2.5}
----------------------------------------

The results of our study show that GFP^+^RFP^−^ ESCs stably maintain a naive pluripotent state when cultured in serum-free N2B27 + LIF + 2i medium. Next, we sought to identify primed PSCs using the double transgenic system. Since the PE regulates *Oct4* expression in EpiSCs ([@bib5], [@bib43]), primed PSCs must be GFP^−^RFP^+^ cells and naive PSCs must be GFP^+^RFP^−^ cells. During EpiSC derivation from O4-DE-GFP^+/−^/O4-PE-RFP^+/−^ epiblasts, the initial expression of GFP decreased and only RFP^+^ cells were expanded ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). Next, we tried to differentiate GFP^+^RFP^+^ ESCs into GFP^−^RFP^+^ EpiSC-like cells (EpiLCs). The GFP^+^RFP^+^ ESCs changed morphologically to form flat colonies that became GFP^−^RFP^+^ cells ([Figure 4](#fig4){ref-type="fig"}A). Heatmap and hierarchical clustering analyses showed that the gene expression patterns of GFP^−^RFP^+^ cells were more similar to EpiSCs than to ESCs ([Figures 4](#fig4){ref-type="fig"}B and 4C). The GFP^−^RFP^+^ cells were more similar to EpiSCs than to 2i-GFP^+^, GFP^+^RFP^−^, or GFP^+^RFP^+^ cells by MDS plot and scatter-plot analyses ([Figures 4](#fig4){ref-type="fig"}D--4G). These results demonstrate that transition of enhancer activity from DE to PE parallels the conversion from the naive to primed pluripotent state. Next, we examined the expression of core pluripotency-, naive pluripotency-, and differentiation-related genes in GFP^−^RFP^+^ EpiLCs ([Figure 4](#fig4){ref-type="fig"}H). *Oct4* and *Nanog* were highly expressed in EpiLCs, EpiSCs, and all ESC lines ([Figure 4](#fig4){ref-type="fig"}H). However, GFP^−^RFP^+^ EpiLCs expressed very low levels of the naive pluripotency-related genes *Klf2*, *Klf4*, *Klf5*, *Dppa3*, *Dppa4*, *Zfp42*, *Tbx3*, and *Tcl1*, as shown for the EpiSCs. However, the differentiation-related genes Krt18, *Fgf5*, *Fgf8*, *Otx2*, *T* (*Brachyury*), and *Nestin* were highly expressed in GFP^−^RFP^+^ EpiLCs and EpiSCs. qRT-PCR analysis confirmed the high expression of the core pluripotency genes (*Oct4* and *Nanog*) and EpiSC markers (*T* and *Fgf5*), and low expression of *Sox2*, *Klf2*, and *Klf4* in GFP^−^RFP^+^ EpiLCs and EpiSCs ([Figure 4](#fig4){ref-type="fig"}G). These data show that GFP^−^RFP^+^ EpiLCs are similar to EpiSCs in terms of morphology and gene expression profiles.

Next, we investigated the DNA methylation status at the promoter regions of *Nanog*, *Stella* (*Dppa3*), and *Dppa5* in GFP^+^RFP^−^, GFP^+^RFP^+^, 2i-GFP^+^RFP^−^, and GFP^−^RFP^+^ EpiLCs ([Figures 4](#fig4){ref-type="fig"}J--4L). The *Nanog* promoter regions were hypomethylated in all samples ([Figure 4](#fig4){ref-type="fig"}J). However, the promoter regions of *Stella* and *Dppa5* were hypermethylated in GFP^−^RFP^+^ EpiLCs ([Figures 4](#fig4){ref-type="fig"}K and 4L). *Long interspersed nuclear element 1* (*LINE1*) and *Intracisternal A particle* (*IAP*) have been shown to be hypermethylated in primed PSCs ([@bib51]). Thus, we examined the DNA methylation status of *LINE1* and *IAP* in GFP^−^RFP^+^ EpiLCs compared with GFP^+^RFP^−^, GFP^+^RFP^+^, and 2i-GFP^+^RFP^−^ cells ([Figures 4](#fig4){ref-type="fig"}M and 4N). The *LINE1* regions were more hypermethylated in GFP^−^RFP^+^ EpiLCs than in GFP^+^ (GFP^+^RFP^−^, GFP^+^RFP^+^, and 2i-GFP^+^RFP^−^) cells ([Figure 4](#fig4){ref-type="fig"}M). The *IAP* regions were more methylated in RFP^+^ cells (GFP^+^RFP^+^ and GFP^−^RFP^+^ EpiLCs) than in GFP^+^RFP^−^ and 2i-GFP^+^RFP^−^ cells ([Figure 4](#fig4){ref-type="fig"}N). Taken together, these results indicate that the *Oct4*-ΔPE-RFP reporter represents an applicable primed PSC marker. Thus, the conversion of ESCs into EpiLCs entails a shift from GFP^+^ to RFP^+^ (i.e., from DE to PE regulation), which also coincides with a change in transcriptome and epigenetic status specific for the primed pluripotent state.

Developmental Potential of GFP^−^RFP^+^ Cells {#sec2.6}
---------------------------------------------

The ability of chimera formation is a strict criterion that distinguishes naive PSCs from primed PSCs ([@bib9], [@bib29], [@bib30]). Naive pluripotent ESCs contribute to chimeras; however, primed pluripotent EpiSCs barely contribute to chimeric embryos subsequent to blastocyst injection followed by transfer to a surrogate mother ([@bib5]). GFP^+^RFP^−^ and GFP^+^RFP^+^ cells as well as GFP^−^RFP^+^ EpiLCs were aggregated with wild-type eight-cell embryos and further cultured until the blastocyst stage. The GFP^+^RFP^−^ and GFP^+^RFP^+^ cells were efficiently incorporated into the ICM of blastocysts ([Figures 5](#fig5){ref-type="fig"}A and 5B). Interestingly, at day 1 post aggregation, incorporated GFP^+^RFP^−^ cells co-expressed RFP, similar to GFP^+^RFP^+^ cells ([Figure 5](#fig5){ref-type="fig"}A). The aggregation efficiency of GFP^+^RFP^−^ and GFP^+^RFP^+^ cells was indistinguishable at 91.1% (41/45) and 93.3% (42/45), respectively ([Figure 5](#fig5){ref-type="fig"}B). However, basically all GFP^−^RFP^+^ EpiLCs failed to incorporate into the ICM of blastocysts, the aggregation efficiency being 0% (0/27) ([Figures 5](#fig5){ref-type="fig"}A and 5B). These results indicate that GFP^+^ cells exhibit characteristics of naive pluripotency and GFP^−^RFP^+^ EpiLCs demonstrate those of primed pluripotency-like EpiSCs.

Control of the DE and PE Elements in Naive and Primed PSCs {#sec2.7}
----------------------------------------------------------

The activity of the *Oct4* enhancers in naive and primed PSCs was evaluated in luciferase assays showing that 2i-GFP^+^ cells mainly use DE for *Oct4* expression while PE was completely inactive; PE is slightly active in the control of ESCs cultured in serum + LIF medium ([Figure 6](#fig6){ref-type="fig"}A). GFP^+^RFP^−^ and GFP^+^RFP^+^ cells in serum + LIF medium also mainly used DE, but the activity of PE was higher than in 2i-GFP^+^ cells. In contrast, the GFP^−^RFP^+^ cells mainly utilized PE for *Oct4* expression, similar to EpiSCs and P19 embryonic carcinoma cells ([Figure 6](#fig6){ref-type="fig"}A). These results confirm that the expression of *Oct4*-ΔPE-GFP and *Oct4*-ΔDE-RFP accurately represents the naive and primed PSC state; thus, the double transgenic reporter system can be used as a tool for purifying populations of naive (2i-GFP^+^ cells) and primed (GFP^−^RFP^+^ cells) PSCs, since the regulatory mechanisms underlying the two different pluripotent states can be precisely defined.

Recent studies have shown that histone modifications are closely associated with the activity of enhancers ([@bib11], [@bib13]). Acetylation of histone H3 lysine 27 (H3K27) is an indicator of active enhancers ([@bib3]), and deacetylation of H3K27 is associated with decreased gene expression or poised enhancers. H3K27me3 and H3K9me3 have also been suggested to be poised enhancer marks ([@bib11], [@bib13]). H3K9me3 can distinguish poised from active enhancers independently of H3K27me3 ([@bib55]). Thus, we investigated the chromatin enrichment state of H3K27ac, H3K27me3, and H3K9me3 in 2i-GFP^+^, GFP^+^RFP^−^, GFP^+^RFP^+^, and GFP^−^RFP^+^ cells ([Figure 6](#fig6){ref-type="fig"}B) using chromatin immunoprecipitation (ChIP)-qPCR analysis. The results of the ChIP-qPCR analysis showed that H3K27ac was highly enriched on the DE and PE of *Oct4* in all *Oct4*-expressing cells, naive (2i-GFP^+^), metastable (GFP^+^RFP^−^ and GFP^+^RFP^+^), and primed (GFP^−^RFP^+^) PSCs ([Figure 6](#fig6){ref-type="fig"}B). The poised enhancer marks H3K27me3 and H3K9me3 were enriched on PE rather than on DE in 2i-GFP^+^ cells. The level of H3K27me3 on the PE was slightly higher than that on DE in metastable cells (GFP^+^RFP^−^ and GFP^+^RFP^+^), but the level of H3K9me3 on the DE and PE did not differ significantly. Therefore, in the metastable state, epigenetic marks seem to fluctuate and the activity of PE and DE cannot be distinguished by histone marks. In primed pluripotent GFP^−^RFP^+^ cells, H3K9me3 was enriched on DE rather than on PE while the level of H3K27me3 was not different. These results suggest that enrichment of H3K9me3 and H3K27me3 on PE indicates the naive pluripotent state and that enrichment of H3K9me3 on DE marks the primed pluripotent state.

Transcription factors can regulate *Oct4* expression by binding to DE and PE ([@bib50]). [@bib16] showed that 2i condition alters the binding enrichment of Nanog on PE in ESCs. Thus we next checked the binding profiles of Nanog on PE and DE of *Oct4* in different cell populations. ChIP-qPCR analysis showed that Nanog was highly enriched on the DE rather than on PE in 2i-GFP^+^ cells, naive PSCs ([Figure 6](#fig6){ref-type="fig"}C). On the other hand, Nanog was more enriched on the PE in GFP^+^RFP^−^ and GFP^+^RFP^+^ cells. These results suggest that the differential activity of DE and PE is closely related to binding affinity of transcription factors.

Since both DNA methylation and histone modification regulate gene expression and affect each other ([@bib7]), we next examined the DNA methylation pattern of the *Oct4* regulatory elements. The DNA methylation status of DE, PE, and PP of *Oct4* were analyzed by bisulfite DNA sequencing analysis ([Figure 6](#fig6){ref-type="fig"}D). The DE, PE, and PP of *Oct4* in naive PSCs (2i-GFP^+^), GFP^+^RFP^−^, and GFP^+^RFP^+^ cells were completely unmethylated. However, primed PSCs (GFP^−^RFP^+^) showed relatively hypermethylated patterns in the DE of *Oct4*, indicating that the DE of *Oct4* in primed PSCs is regulated by DNA methylation as well as H3K9me3 ([Figures 6](#fig6){ref-type="fig"}B--6D).

Discussion {#sec3}
==========

In this study, we show that DE and PE coordinately regulate *Oct4* expression during embryonic and germ cell development in vivo and naive and primed pluripotency in vitro. The cell-specific and temporal control of DE and PE could be precisely determined using the dual reporter system. Approximately two decades ago, we first determined the activity of the genomic fragment containing *Oct4* using a β-galactosidase reporter and found that DE activity was ESC- and germ cell-specific and that PE was epiblast- and embryonic carcinoma cell (P19)-specific ([@bib52]). *Oct4*-GFP transgenic mice have been generated and used for the detection of PGCs and PSCs and for monitoring reprogramming through nuclear transfer, cell fusion, and the transduction of reprogramming factors ([@bib2], [@bib10], [@bib12]). However, these existing transgenic systems cannot concurrently discriminate between the activity of DE and PE. In this study, a developed dual reporter system allowed us to monitor the DE, PE, and DE + PE activity simultaneously.

Enhancers play a central role in cell-type-specific and stage-specific regulation of gene expression and are capable of acting over a distance ranging from several to hundreds, and in rare cases even thousands of kilobases from their target genes ([@bib6], [@bib33], [@bib34]). In developing mouse embryos, *Oct4* gene expression is regulated spatially and temporally by at least two enhancers, DE and PE ([@bib52]). Here we have elucidated the control of *Oct4* expression by its DE and PE elements during the totipotent cycle ([Figure 7](#fig7){ref-type="fig"}A). The *Oct4* gene is expressed under the control of the DE during the pre-implantation stage, but its expression is controlled by PE in the epiblast subsequent to implantation ([Figure 7](#fig7){ref-type="fig"}A; [@bib38]). Expression of the *Oct4* gene is downregulated in epiblasts and expressed exclusively in the developing germline. In founder PGCs, *Oct4* is initially controlled by DE but subsequently by both DE and PE ([Figures 1](#fig1){ref-type="fig"}E--1J and [7](#fig7){ref-type="fig"}A). Interestingly, we found that *Oct4* was expressed not only in spermatogonia but also in differentiating germ cells; in adult mice, *Oct4* expression was regulated by DE in spermatogonia but by PE in differentiating germ cells. It is well known that PGCs first emerge at the proximal region of the epiblast adjacent to the extraembryonic ectoderm and then migrate to form the PGC cluster at 7.25 dpc ([@bib17], [@bib36]). However, while our dual reporter system could not distinguish the PGC population at 7.25 dpc, *Oct4*-ΔPE-GFP PGCs were apparent in 8.5-dpc embryos. Intriguingly, migrating PGCs in 9.5- and 10.5-dpc embryos contained two subpopulations, GFP^+^RFP^−^ and GFP^+^RFP^+^ cells, and the GFP^+^RFP^+^ cell population increased during PGC migration into the genital ridge. Since genome-wide epigenetic modification, including imprinting erasure, occurs in migrating PGCs ([@bib37]), further experiments are required to examine the differences between these two migrating PGC populations and whether they can be distinguished using genome-wide epigenetic markers.

This study showed that ICM cells initially express only GFP but express both GFP and RFP during the derivation of ESCs ([Figure 2](#fig2){ref-type="fig"}B). This result supports the findings of recent studies indicating that the ability of ICM cells to self-renew as ESCs is acquired during epiblast specification ([@bib4], [@bib42]). [@bib4] also suggested that early ICM cells are distinct from ESCs and that ESCs exhibit the greatest degree of identity to the embryonic day 4.5 (E4.5) epiblast. Our results confirm that the switch in enhancer activity occurs at approximately the E4.5 stage ([@bib52]), and enhancer activity of DE and PE overlapped in early post-implantation epiblast (5.5--6.5 dpc).

Self-renewing ESCs cultivated in conventional ESC culture medium (supplemented with LIF and serum) constitute a cell population at various stages of pluripotency ([@bib22], [@bib27], [@bib28]). A defined ESC culture system, containing 2i (MEK inhibitor PD0325901 and glycogen synthase kinase 3 inhibitor CHIR99021) ([@bib54]) together with LIF (2i + LIF) has been used to select naive pluripotent cells ([@bib40]). Here we show that ESCs from 2i + LIF medium still contain two cell populations when cultured in serum-containing medium and that the mixed population could be converted to homogeneous naive PSCs by using serum-free N2B27 medium. This result indicates that serum contains a factor(s) that induce differentiation or inhibit maintenance of naive pluripotency. Previous reports have suggested that serum contains ERK phosphorylation-inducing factors ([@bib51]). [@bib40] also showed that the presence of MEK inhibitor in serum-containing medium accelerated the activation of *Nanog* and *Rex1* during reprogramming. This is also supported by the findings that GFP^+^RFP^−^ ESCs cultured in serum-containing medium were molecularly distinguishable from GFP^+^RFP^−^ ESCs cultured in serum-free medium. Collectively, the GFP^+^RFP^−^ state is a necessary but not sufficient condition for naive PSCs, since special medium is also required for maintaining naive PSCs. Several reporter systems suggested that undifferentiated ESCs heterogeneously expressed *Nanog* ([@bib8]), *Rex1* ([@bib26], [@bib46]), *Stella* ([@bib22]), *Esrrb* ([@bib48]), and *Tbx3* ([@bib32]). The heterogeneity of transcription factors in ESCs regulated self-renewal capacity, expression of developmental genes, and differentiation potential ([@bib45]). However, the GFP^+^RFP^−^ and GFP^+^RFP^+^ ESCs in serum-containing medium are similar to each other at the transcriptional, epigenetic, and functional levels. Our dual transgenic system allows monitoring of enhancer activity of DE and PE, but not *Oct4* expression levels. Although enhancer activity fluctuates between GFP^+^RFP^−^ and GFP^+^RFP^+^ in serum-containing medium, these cells highly expressed *Oct4* gene.

Mixed populations of PSCs were also converted to naive PSCs in 2i + LIF medium without serum or to primed EpiLCs in bFGF + activin medium. EpiLCs induced from ESCs expressed only RFP, and the RFP^+^ EpiLCs were indistinguishable from EpiSCs in terms of morphology, gene expression patterns, epigenetic status, and defective incorporation into ICM of blastocysts. Therefore, GFP^−^RFP^+^ state constitute a definitive marker of primed PSCs; GFP^−^RFP^+^ cells were not observed in any of the three different ESC culture media.

The conversion from GFP^+^RFP^+^ to GFP^+^RFP^−^ cells and vice versa takes place within 2 days of changing the culture medium ([Figure 2](#fig2){ref-type="fig"}), indicating that the conversion of enhancer activity occurs within 2 days. It has been suggested that genome-wide demethylation and transcriptional changes occur in mouse ESCs within the first 24 hr of 2i addition ([@bib14]). Therefore, the regulatory machinery of *Oct4* enhancers seems to change rapidly in response to external cues accompanying epigenetic modification.

GFP^−^RFP^+^ EpiLCs derived from transgenic ESCs showed the molecular signature of EpiSCs, including expression of EpiSC markers and hypermethylation of germ cell markers (*Stella* and *Dppa5* region), *LINE1*, and *IAP*. Primed PSCs are derived from post-implantation stage epiblasts and express *Oct4* for self-renewal under the control of the PE ([@bib5], [@bib43]). RFP^+^ cells were not incorporated into the ICM by aggregation with normal embryos. Although a single aggregated embryo with RFP^+^ cells was observed, the GFP^−^RFP^+^ cells did not contribute to the ICM ([Figure S6](#mmc1){ref-type="supplementary-material"}). This result could support the observation that GFP^−^RFP^+^ cells formed a pure population of primed PSCs.

Finally, we showed that the activity of the two *Oct4 cis*-regulatory elements was controlled by DNA methylation and histone modification concurring with the naive or primed pluripotency state. Consequently, the differential activity of DE and PE was closely related to binding affinity of Nanog on the two enhancers; Nanog was highly enriched on the DE in naive PSCs, but highly enriched on the PE in primed PSCs ([Figures 6](#fig6){ref-type="fig"}C and [7](#fig7){ref-type="fig"}B). We also found that the activity of *Oct4* DE and PE is affected by the repressive histone marks, H3K9me3 and H3K27me3, and DNA methylation in a cell-type-specific manner. The enhancers of *Oct4* in primed PSCs is regulated by DNA methylation as well as H3K9me3, but those in naive PSCs is regulated by H3K9me3 and H3K27me3 but not by DNA methylation; DNA methylation was only correlated with inactive DE in primed PSCs and not with inactive PE in naive PSCs ([Figure 7](#fig7){ref-type="fig"}B). Thus, demethylation of the PE region seems to be the default state for PSCs and methylation of DE could constitute an epigenetic marker for primed PSCs. In contrast, H3K27ac was enriched in both the DE and PE of naive and primed PSCs, indicating that H3K27ac cannot be a histone mark for the active state of the *Oct4* DE and PE. Another explanation is that although one of the enhancers is not active based on fluorescent reporter expression, epigenetically these enhancer elements of *Oct4* are basically not completely silenced as H3K27ac remains enriched in both naive and primed PSCs. Similarly the PE is not methylated in 2i/LIF conditions, although the fluorescent mark is not on. These results suggest that overall both enhancers are active and never fully silenced in any of the states, although their level of activity is different under the tested conditions. Thus we should be more careful against using of terms "off" and "on" when describing enhancer activity of *Oct4*, the more accurate term rather being "dominant activity." This fact could also be the reason for the need of a dual reporter system for accurate separation of naive and primed PSCs.

In this study, we showed that enhancer-specific regulation of *Oct4* could constitute a determinant for distinguishing between naive and primed pluripotency. This is based on the ability to accurately separate naive and primed PSCs using the dual reporter system, thereby obtaining pure populations of naive and primed pluripotent cells, which could be used for accurate analysis of distinct cell states. The dual reporter system could also be a useful tool for monitoring cellular reprogramming to naive or primed states as well as embryonic development under live-cell conditions.

Experimental Procedures {#sec4}
=======================

Generation of O4-DE-GFP/O4-PE-RFP Mouse {#sec4.1}
---------------------------------------

To generate the *Oct4*-ΔDE-RFP transgene, we inserted the tdTomato (RFP) gene into genomic *Oct4* fragments of 6 kb in length (GOF6), which lack DE ([@bib52]). *Oct4*-ΔDE-RFP transgene expresses tdTomato transgene under the control of *Oct4* PE and PP. O4-PE-RFP embryos were generated by injecting Oct4-ΔDE-RFP (O4-PE-RFP) plasmid into normal zygote, which were developed to blastocysts. O4-PE-RFP blastocysts were transferred into the uterus of a pseudo-pregnant female mouse. We first generated five O4-PE-RFP founder transgenic mice, two male and three female ([Figure S1](#mmc1){ref-type="supplementary-material"}). OG2 mice were purchased from the Jackson Laboratory and maintained in the mouse facility, and used for O4-DE-GFP founder mice ([@bib41]). The O4-PE-RFP mouse was crossed with homozygous O4-DE-GFP mouse. Finally, we generated O4-DE-GFP^+/−^ O4-PE-RFP^+/−^ mice carrying both *Oct4*-ΔPE-GFP and *Oct4*-ΔDE-RFP.

ESC Derivation and Culture {#sec4.2}
--------------------------

ESC lines from blastocyst were derived essentially as described previously ([@bib31]). Embryos at the eight-cell stage were flushed from oviducts of C57/BL6 mice mated with male O4-DE-GFP/O4-PE-RFP mice at 2.5 dpc, cultured in G2 medium for 2 days, and transferred to conventional ESC medium with 15% fetal bovine serum (FBS), 1× penicillin/streptomycin/glutamine, 0.1 mM nonessential amino acids, 1 mM β-mercaptoethanol, and 10^3^ units/mL LIF on feeder layers. The established ESCs in conventional ESC medium were transferred into conventional ESC medium supplemented with LIF and 2i inhibitors, CHIR99021(3 μM) and PD0325901 (1 μM), or serum-free N2B27 medium supplemented with LIF and 2i inhibitors. The serum-free N2B27 was prepared as described by [@bib53].

EpiSCs-like Cell Differentiation from ESCs {#sec4.3}
------------------------------------------

EpiLCs from ESCs were derived essentially as described previously ([@bib23]). The EpiLCs were induced by plating 1.0 × 10^5^ ESCs on a well of a 12-well plate on a feeder layer or feeder free in N2B27 medium containing activin A (20 ng/mL), bFGF (12 ng/mL), and knockout serum replacement (1%). The medium was changed every day. The differentiated EpiLCs (*Oct4*-ΔDE-RFP-positive cells) were passaged every 2--3 days by dissociation with 1 mg/mL collagenase type IV (Invitrogen) or by pipetting with a glass pipette.
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![Generation of Dual Transgenic Mice (O4-DE-GFP/O4-PE-RFP) and the Distinct *Oct4* Regulatory Elements in the Totipotent Cycle\
(A) Physical maps of wild-type endogenous *Oct4*, *Oct4*-ΔPE-GFP (O4-DE-GFP), and *Oct4*-ΔDE-RFP (O4-PE-RFP).\
(B) The expression pattern of O4-DE-GFP and O4-PE-RFP in pre-implantation embryos (2C, blastocyst). The O4-DE-GFP/O4-PE-RFP pre-implantation embryos expressed only O4-DE-GFP. Scale bars, 50 μm.\
(C--H) The expression pattern of O4-DE-GFP and O4-PE-RFP in post-implantation embryos. Phase and fluorescence images of (C) 6.5-dpc embryo (scale bar, 100 μm); (D) 7.25-dpc embryo (scale bar, 100 μm); (E) 8.5-dpc embryo (scale bar, 100 μm); (F) 9.5-dpc embryo and migrating PGCs (scale bar, 100 μm); (G) 10.5-dpc embryo and PGCs (scale bar, 100 μm); and (H) 13.5-dpc embryo and gonad (scale bar, 100 μm). Arrowheads indicate GFP-positive areas in the developing gonads.\
(I and J) The expression pattern of O4-DE-GFP and O4-PE-RFP in testis. Phase and fluorescence image of (I) 7-dpp testis and seminiferous tubules and (J) 4-week-old adult mouse testis and seminiferous tubules. Scale bars, 100 μm.\
(K) The neurosphere did not express either O4-DE-GFP or O4-PE-RFP. Scale bar, 100 μm.](gr1){#fig1}

![ESC Culture Conditions Influence the Activity of *Oct4* Enhancers\
(A and B) Derivation of ESCs from O4-DE-GFP/O4-PE-RFP blastocysts. O4-PE-RFP was initially expressed during the establishment of ESCs. Scale bars, 50 μm.\
(C) Phase and fluorescence images of O4-DE-GFP/O4-PE-RFP ESCs in serum + LIF medium. Scale bars, 50 μm.\
(D) Flow cytometry analysis of the proportion of O4-DE-GFP^+^ only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells in serum + LIF medium.\
(E) Flow cytometry analysis of the proportion of O4-DE-GFP^+^ only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells from sorted O4-DE-GFP^+^ only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells cultured in serum + LIF medium for ten passages.\
(F) Phase and fluorescence images of O4-DE-GFP/O4-PE-RFP ESCs in serum + LIF + 2i medium. Scale bars, 50 μm.\
(G) Flow cytometry analysis of the proportion of O4-DE-GFP^+^ only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells in serum + LIF + 2i medium.\
(H) Flow cytometry analysis of the proportion of O4-DE-GFP^+^ only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells from sorted O4-DE-GFP^+^only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells cultured in serum + LIF + 2i medium for ten passages.\
(I) Phase and fluorescence images of O4-DE-GFP/O4-PE-RFP ESCs in N2B27 + LIF + 2i medium. Scale bars, 50 μm.\
(J and K) Flow cytometry analysis of the proportion of O4-DE-GFP^+^ only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells cultured in N2B27 + LIF + 2i medium for 2 days (J) or ten passages (K).\
(L) Flow cytometry analysis of the proportion of O4-DE-GFP^+^ only cells or O4-DE-GFP^+^ and O4-PE-RFP^+^ cells cultured in serum + LIF medium for 2 days from N2B27 + LIF + 2i medium.](gr2){#fig2}

![2i-GFP-Positive Cells Cultivated in N2B27 + LIF + 2i Medium and GFP- or GR-Positive Cells Cultivated in Serum + LIF Medium Exhibit Distinct Gene Expression Patterns\
(A) Heatmap of global gene expression patterns in 2i-GFP^+^, GFP^+^RFP^−^ (GFP), and GFP^+^RFP^+^ (GR) cells.\
(B and C) Hierarchical clustering (B) and MDS plot (C) analysis showing that 2i-GFP-positive cells are distinct from GFP- or GR-positive cells.\
(D--F) Scatter plots of global gene expression comparing (D) 2i-GFP- and GFP-positive cells, (E) 2i-GFP- and GR-positive cells, and (F) GFP- and GR-positive cells.\
(G) Heatmap analysis shows that GFP-positive cells express germ cell-related genes including *Wnt3a*, *Rhox5*, *Rhox6*, *Rhox9*, *Nanos3*, and *Tcfap2c* at a higher level than do GR-positive cells.\
(H) Heatmap analysis showing that 2i-GFP-positive cells highly express naive pluripotency-related genes and GFP- and GR-positive cells highly express differentiation markers.\
(I) Quantitative gene expression analysis of pluripotency markers (*Oct4*, *Nanog*, *Sox2*, *Esrrb*), naive pluripotency markers (*Rex1*, *Klf2*, *Klf4*, *Tcl1*, *Tbx3*, *Prdm14*), and differentiation markers (*Dnmt1*, *Dnmt3a*, *Dnmt3b*, *T*, *Fgf5*). Data are presented as mean ± SEM for n = 3 independent experiments. *GAPDH* was used as a housekeeping gene.](gr3){#fig3}

![*Oct4*-ΔDE-RFP-Positive Cells Constitute Primed Pluripotent Stem Cells, as Determined by Gene Expression Patterns and Epigenetic Status\
(A) Phase and fluorescence images of EpiSC-like cells (EpiLCs) from O4-DE-GFP/O4-PE-RFP ESCs. These EpiLCs express *Oct4*-ΔDE-RFP but not *Oct4*-ΔPE-GFP. Scale bars, 100 μm.\
(B) Heatmap of global gene expression patterns in 2i-GFP^+^, GFP^+^RFP^−^ (GFP^+^), GFP^+^RFP^+^ (GR), GFP^−^RFP^+^ (RFP) cells, ESCs, EpiSCs, and mouse embryonic fibroblasts (MEF).\
(C and D) Hierarchical clustering and MDS plot analyses showing that RFP-positive cells are more similar to EpiSCs than to ESCs, 2i-GFP^+^, GFP^+^, or GR^+^ cells.\
(E--G) Scatter plots of global gene expression comparing (E) EpiSCs and GFP-positive cells, (F) EpiSCs and GR-positive cells, and (G) EpiSCs and RFP-positive cells.\
(H and I) Heatmap (H) and quantitative gene expression (I) analysis show that RFP-positive cells do not express naive pluripotency-related genes but highly express primed pluripotency-related genes. Data are presented as mean ± SEM for n = 3 independent experiments. *GAPDH* was used as a housekeeping gene.\
(J--N) Bisulfite genomic sequencing of the *Nanog* (J), *Stella* (K), *Dppa5* (L), *LINE* (M), and *IAP* (N) regions in 2i-GFP^+^, GFP^+^, GR^+^, and RFP^+^ cells. Black and white circles represent methylated and unmethylated CpGs, respectively.](gr4){#fig4}

![In Vivo Development Potential of *Oct4*-ΔDE-RFP-Positive Cells\
(A) Aggregation of GFP-, GR-, and RFP-positive cells with normal embryo. RFP-positive cells did not incorporate into the embryos. Scale bars, 50 μm.\
(B) Aggregation efficiency of GFP-, GR-, and RFP-positive cells.](gr5){#fig5}

![Epigenetic Status of *Oct4* Regulatory Elements in Naive and Primed Pluripotent Stem Cells\
(A) Analysis of *Oct4* enhancer activity in ESCs, 2i-GFP^+^ cells, GFP^+^ GR^+^ cells, RFP^+^ cells, EpiSCs, and P19 embryonic carcinoma cells. Relative luciferase activity was normalized to the activity of the empty vector. Data are presented as mean ± SEM for n = 3 independent experiments.\
(B) ChIP-qPCR analysis to determine immunoglobulin G (IgG), H3K27ac, H3K27me3, and H3K9me3 enrichment on the *Oct4* distal and proximal enhancers. Data are presented as mean ± SEM for n = 3 independent experiments. Coloured stars indicate histone tails, such as H3K9 and H3K27.\
(C) ChIP-qPCR analysis to determine IgG and Nanog enrichment on the *Oct4* distal and proximal enhancers. Data are presented as mean ± SEM for n = 3 independent experiments.\
(D) Bisulfite genomic sequencing of the regions of the *Oct4* DE, PE, and PP in 2i-GFP^+^, GFP^+^, GR^+^, and RFP^+^ cells, and MEF. Black and white circles represent methylated and unmethylated CpGs, respectively.](gr6){#fig6}

![Schematic Representation of the *Oct4* Regulatory Elements\
(A) The regulatory element of *Oct4* during the totipotent cycle.\
(B) Epigenetic status of the *Oct4* enhancer in naive and primed pluripotency.](gr7){#fig7}
